Ishihara S, Hiramatsu M, Kameyama T, Nabeshima T
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Japan.
J Neural Transm Gen Sect. 1993;91(1):27-37. doi: 10.1007/BF01244916.
Repeated administration of benzodiazepines has been reported to produce tolerance in animals and humans. Using an elevated plus-maze test and an autoradiographic technique, we investigated whether repeated administration of chlordiazepoxide produced tolerance to its anxiolytic effects, and whether such repeated administration altered benzodiazepine and GABAA receptors. Tolerance to the anxiolytic effect of chlordiazepoxide was produced when it was administered at a dose of 30 mg/kg (i.p.) once a day for 10 and 14 days. In the quantitative autoradiographical study, although repeated chlordiazepoxide treatment had no effect on [3H]flunitrazepam and [3H]Ro 15-4513 binding to benzodiazepine receptors, such treatment reduced [3H]muscimol binding to GABAA receptors in the cortex, caudate putamen, and hippocampus. These results suggest firstly, the production of tolerance to the anxiolytic effects of chlordiazepoxide, and, secondly, that this tolerance may be due to the down-regulation of GABAA receptors, but not of benzodiazepine receptors.
据报道,苯二氮䓬类药物的反复给药会在动物和人类中产生耐受性。我们采用高架十字迷宫试验和放射自显影技术,研究了反复给予氯氮䓬是否会使其抗焦虑作用产生耐受性,以及这种反复给药是否会改变苯二氮䓬受体和GABAA受体。当氯氮䓬以30mg/kg(腹腔注射)的剂量每天给药一次,持续10天和14天时,会产生对其抗焦虑作用的耐受性。在定量放射自显影研究中,尽管反复给予氯氮䓬治疗对[3H]氟硝西泮和[3H]Ro 15-4513与苯二氮䓬受体的结合没有影响,但这种治疗会降低[3H]蝇蕈醇与皮质、尾状壳核和海马体中GABAA受体的结合。这些结果表明,首先,氯氮䓬的抗焦虑作用产生了耐受性;其次,这种耐受性可能是由于GABAA受体的下调,而不是苯二氮䓬受体的下调。